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Abstract
Background: Both acute hyperglycemia as diabetes results in an impaired prognosis in ST-elevation myocardial
infarction (STEMI) patients. It is unknown whether there is a different prevalence of diabetes and acute
hyperglycemia in men and women within age-groups.
Methods: Between 2004 and 2010, 4640 consecutive patients (28% women) with STEMI, were referred for primary
PCI. Patients were stratified into two age groups, < 65 years (2447 patients) and ≥65 years (2193 patients). Separate
analyses were performed in 3901 patients without diabetes. Diabetes was defined as known diabetes or HbA1c ≥6.5
mmol/l at admission.
Results: The prevalence of diabetes was comparable between women and men in the younger age group (14% vs
12%, p = 0.52), whereas in the older age group diabetes was more prevalent in women (25% vs 17% p < 0.001). In
patients without diabetes, admission glucose was comparable between both genders in younger patients (8.1 ± 2.0
mmol/l vs 8.0 ± 2.2 mmol/l p = 0.36), but in older patients admission glucose was higher in women than in men (8.7 ±
2.1 mmol/l vs 8.4 ± 2.1 mmol/l p = 0.028). After multivariable analyses, the occurrence of increased admission glucose
was comparable between men and women in the younger age group (OR 1.1, 95%CI 0.9-1.5), but increased in women
in the older age group (OR 1.3, 95% CI 1.1-1.7). Both diabetes and hyperglycemia were associated with a higher one-
year mortality in both men and women.
Conclusions: The differences between men and women in hyperglycemia and diabetes in patients with STEMI are age
dependent and can only be observed in older patients. This may have implications for medical treatment and should
be investigated further.
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Background
Both hyperglycemia and diabetes are independent predic-
tors of impaired prognosis after ST elevation myocardial
infarction (STEMI) [1-4]. Prevalences of both hypergly-
cemia and diabetes in STEMI are increased in women,
which in part may explain their higher mortality rates
[1,5,6]. Moreover, diabetes has been associated with a
higher cardiovascular mortality in women compared to
men [7-9]. In the general population however, only in
elderly people diabetes is more often present in women
than in men [10]. Until now, data with regard to the
impact of age on the difference in prevalence of hypergly-
cemia and diabetes between men and women with STEMI
are lacking. We investigated whether the differences in
both hyperglycemia and diabetes are age-dependent within
a large registry of patients with STEMI, treated with primary
percutaneous coronary intervention (PCI).
Methods
We performed an observational study including all
consecutive patients admitted with STEMI, referred for
primary PCI to our hospital between 2004 and 2010.
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Within these time frames, HbA1c and glucose were rou-
tinely measured on admission in all STEMI patients.
Patients were diagnosed with STEMI if they had chest
pain longer than 30 minutes and ECG changes with ST
elevation greater than 2 mm in at least two precordial
leads or greater than 1 mm in the limb leads. All pa-
tients were directly transported to the catheterization
4laboratory on arrival, and acute coronary angiography
was performed with subsequent PCI when indicated as
part of the routine treatment for all STEMI patients.
The interventional strategy was at the operator’s discre-
tion. All patients were pretreated with aspirin, heparin,
and clopidogrel during transportation to the hospital
according to protocol, or these drugs were administered
at the emergency ward. Cardiac biomarkers were ele-
vated in all patients. Diabetes was defined as known dia-
betes or a HbA1c ≥ 6.5 at admission. This HbA1c value
was identified by the American Diabetes Association as
diagnostic for diabetes mellitus [11]. We performed add-
itional analysis on a group without diabetes in order to
concentrate on acute hyperglycemia due to stress. We
conducted a multivariate analysis with gender as a pre-
dictor of a higher than median glucose levels. We
corrected for confounders based on previously described
variables in the literature [1,8]. Therefore, the multivari-
ate model consisted of gender, TIMI flow, Killip class
and age.
Data collection
Patient characteristics were registered into a dedicated
database. Thrombolysis in Myocardial Infarction (TIMI)
[12] flow was scored according to the TIMI flow grading
system before and after PCI. Follow-up information was
obtained with pre-defined time intervals of 30 days and
one year using the outpatient files or by direct telephone
interview by independent research nurses not involved
in patient treatment., The HbA1c levels were measured
on the Primus Ultra 2 affinity chromatography-HPLC
(Primus Diagnostics, Kansas City, MO) with a within-
run coefficient of variation of < 0.5%. The reference nor-
mal values in non diabetics were 4.0% to 6.5%. Glucose
levels were measures with a Modular device (Roche
Diagnostics). The reference values did not change during
the study period and yearly numeric quality control data
revealed that the coefficient of variation remained < 2%.
Statistical analysis
Statistical analysis was performed using SPSS version
17.0 (SPSS Inc, Chicago, IL). Continuous data were
expressed as median and inter quartile range and cat-
egorical data as percentages. In order to examinate dif-
ferences in women and men, we performed the Chi2 test
for categorical variables and one-way Anova for continu-
ous variables. The test for significance were two-sided
with an α of < 0.5%. Multivariate analyses were per-
formed using binary logistic regression. Predictors were
identified using forward, stepwise logistic regression with
the likelihood ratio test of all baseline variables with an
α ≥ 0.1. The three most significant values and gender
were entered into the final multivariate model. Kaplan
Meier was performed with the log rank test for the
p-values.
Results
A total of 4640 patients with STEMI were admitted
between 2004 and 2010. Mean age of the total popula-
tion was 64 ± 13 years, including 1291 women (28%).
In the total population, the prevalence of hypertension
was 36%, smoking 41% and hypercholesterolemia 21%. A
total of 464 (10%) patients had a previous myocardial
infarction.
Effect of age
In older women, a higher killip class was observed com-
pared to men. This difference was not present in the
younger age group. The prevalence of known diabetes
was 10% in men en 16% in women in the total study
group (p < 0.001). Undetected diabetes was observed in
4% of men and in 5% of women (p = 0.80), resulting in a
significantly different prevalence of diabetes between
both genders (p < 0.001). Diabetes was associated with
an increased one-year mortality in both men (OR 1.9,
1.4-2.8 95% CI) and women (OR 2.1, 1.4-3.2 95% CI).
In the older age group the prevalence of diabetes was
higher in women, while in the younger age group the
prevalence was comparable (Table 1 and Figure 1).
Hyperglycemia in patients without diabetes
A total of 3901 patients had no diabetes, consisting of
1029 women (26%). Of the total group, 1761 patients
(45%) were aged ≥65 years. Mean admission glucose was
associated with both age and gender. Mean admission
glucose was 8.2 ± 2.2 mmol/l in men and 8.5 ± 2.1 in
women (p = 0.001). The mean admission glucose was
8.3 ± 2.6 mmol/l in younger patients and 8.9 ± 2.6 mmol/
l in older patients (p < 0.001).
Baseline characteristics of the 3901 patients, stratified
to age group and gender are summarized in Table 2. Be-
sides differences in history of hypertension and smoking
there were no significant differences in risk factors
between men and women in the patient group below 65
years of age. In the older patient group however, men
had more often a previous history of cardiovascular
disease (prior PCI, CABG, myocardial infarction or stroke)
while women were more often known with hypertension.
Glucose level at admission was comparable between
men and women in the younger age group, but higher in
women at older age (Table 2) Also, the prevalence of
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admission glucose above the median was comparable
within both genders at younger age in the multivariate
model (OR 1.1, 0.9-1.5 95% CI) while in the older age
group, admission glucose above the median was more
frequent in women. (OR 1.3, 1.1-1.7 95% CI) This age-
related difference remained after multivariate analyses.
In patients without diabetes, acute hyperglycemia was
associated with an increased one-year mortality in both
men (OR 2.2, 1.5-3.4 95% CI) and women (OR 2.9, 1.6-
5.4 95% CI).
Mortality curves for patients without a history of dia-
betes are dichotomized into higher and lower than median
glucose in women (8.1 mmol/l) and men (7.8 mmol/l) are
depicted in Figure 2.
Discussion
In our present study of patients treated with primary
PCI for STEMI the prevalence of diabetes was higher in
older women compared to similarly aged men. In youn-
ger patients, however, we found no differences between
men and women. Also, in patients without diabetes, a
higher admission glucose could only be demonstrated in
older women as compared to older men. Both diabetes
and increased admission glucose in patients without
diabetes, were associated with a higher one-year mortal-
ity in both women and men.
Our study confirmed the increased prevalence of dia-
betes and acute hyperglycemia in women compared to
men [5-7]. A new finding however in STEMI patients is
that this association is age-dependent and only present in
the older age-group. Diabetes (both known and unknown)
confers to a greater risk for adverse cardiovascular events
in women than in men [6,7]. Therefore, the increased risk
induced by diabetes in patients presenting with STEMI is
predominantly observed in older women.
In assessing the risk of adverse events in patients pre-
senting with STEMI, both age and gender are important
factors to consider. Importantly, the increased prevalence
of diabetes in older women compared to older man is part
of a different risk profile. Consistent with the literature,
we found that men more frequently had ischemic heart
disease in the medical history [6,7]. Hypertension however
was more common in both older and younger women,
and this is interesting because hypertension has been asso-
ciated with the development of diabetes [13-15]. Hyper-
tension may be an early sign of microvascular disease and
increased risk of pre-diabetes and STEMI in (aging)
women. The association between hypertension and dia-
betes is also important, since both risk factors induce
microvascular and more diffuse coronary artery disease,
which is more prevalent in older women [16-19].
Our findings may have implications for medical treat-
ment for patients with STEMI, since it has been shown
that some antiplatelet drugs are more effective in pa-
tients with diabetes [20,21]. Particularly since older
women with abnormal glucose metabolism have a worse
prognosis, optimal medical treatment is mandatory in
this subgroup.
It is important to discriminate diabetes from acute
hyperglycemia at admission [1,22]. High admission
glucose in patients with diabetes is mainly due to
glucose intolerance in the setting of diabetes. Whereas
in patients without diabetes, hyperglycemia is prob-
ably associated with acute stress, induced by abnor-
mal hemodynamics [1,23,24].
There are several explanations for the increased preva-
lence of acute hyperglycemia in older women without
Table 1 Prevalence of diabetes in the total study population (n = 4640) according to gender and age group
Women Men p-value Women Men p-value
<65 <65 ≥65 ≥65
N = 508 N = 1939 N = 783 N = 1410
History of diabetes 54(11%) 157(8%) 0.15 155(20%) 184(13%) <0.001
Newly detected diabetes* 13(3%) 77(4%) 0.16 35(4%) 51(4%) 0.17
Total without chronic diabetes 439(86%) 1701(88%) 0.52 590(75%) 1171(83%) <0.001
Missing 2 4 3 4
* Patients without previously known diabetes and HbA1c ≥ 6.5% mmol/L.
Figure 1 Prevalence diabetes in STEMI patients according to
age and gender.
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diabetes. Firstly, although we excluded patients with in-
creased HbA1c, several older women may have had abnor-
mal chronic glucose metabolism. Therefore, women are
more susceptible for hyperglycemia in response to a stres-
sor, as compared to patients with completely normal glu-
cose metabolism. Secondly, older women with STEMI
may have had more acute stress as there is evidence that
women more often present with cardiogenic shock com-
pared to men [25]. Also, in our study population older
women had more often signs of heart failure on admission
as compared to older men, whereas in the younger age
group there was no difference in heart failure between
men and women. However, after adjustment for the ob-
served differences in heart failure, we found that older
women still had increased admission glucose levels.
Finally, gender-differences to stress in STEMI patients
may be more present in elderly woman than in similarly
aged men.
Table 2 Baseline Characteristics according to gender and age groups <65 and ≥65 years in 3901 patients admitted for
primary angioplasty for ST-segment elevation myocardial infarction (STEMI) without diabetes
Women Men p-value Women Men p-value
<65 <65 ≥65 ≥65
N = 439 N = 1701 N = 590 N = 1171
Age (year) 55(48–60) 54(49–59) 0.41 75(70–81) 73(69–78) <0.001
History of, n (%)
MI 19(4%) 113(7%) 0.07 39(7%) 176(15%) <0.001
CABG 5(1%) 30(2%) 0.36 13(2%) 67(6%) 0.001
PCI 21(5%) 117(7%) 0.11 36(6%) 141(12%) <0.001
Stroke 5(1%) 21(1%) 0.87 17(3%) 57(5%) 0.05
Risk factors
History of hypertension 142(32%) 431(26%) 0.004 267(45%) 432(37%) 0.001
Positive family history 227(53%) 841(51%) 0.43 170(30%) 310(27%) 0.34
Current smoking 280(65%) 963(57%) 0.004 123(21%) 263(23%) 0.41
Hypercholesterolemia 65(15%) 320(19%) 0.06 99(17%) 205(18%) 0.66
Admission data
Glucose (mmol/l) 8.2 ± 2.2 8.0 ± 2.2 0.36 8.7 ± 2.1 8.4 ± 2.1 0.03
Killip class = 1 412(94%) 1619(96%) 0.22 519(88%) 1066(91%) 0.05
TIMI-3 before PCI 105(27%) 335(22%) 0.06 116(24%) 219(22%) 0.36
Continuous variables are displayed as median and interquartile range.
Figure 2 Kaplan Meier mortality curves for patients without a history of diabetes, dichotomized into higher and lower than median
glucose and stratified to gender (n = 3901).
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Our study has several limitations. The number of pa-
tients in some subgroups were small, and the study was
not powered to detect small differences between these
subgroups. Also, the sample size was too small to dem-
onstrate survival differences between men and women
within the different age groups. Information regarding
renal failure, liver failure, obesity, physical activity, in-
flammatory markers and socioeconomic status were
lacking. Therefore, we were unable to adjust for these
potential confounders. Finally, our data cannot be ex-
trapolated to non-STEMI patients,non-cardiac patients
admitted to intensive care wards, or unstable patients
since our study included only STEMI patients and only
8% of these patients had a killip class higher than 1.
Conclusion
In STEMI, diabetes and hyperglycemia on admission is
more prevalent in older women compared to similarly
aged men. This association was not prevalent in younger
patients. We observed an independent increased risk of
acute hyperglycemia in older women without diabetes and
therefore, older women may have an increased stress
response. Both acute hyperglycemia and diabetes are asso-
ciated with a worse prognosis in both women and men.
More research is needed to elucidate these age-dependent
gender differences and to explore whether tailored treat-
ment can improve prognosis.
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